The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Rubella
Open accessAbstract
Rubella remains an important pathogen globally with approximately 100,000 cases of congenital rubella syndrome estimated to occur each year. Rubella vaccine is highly effective and safe when used across a population and, as a result, endemic rubella transmission has been interrupted in the Americas since 2009. Incomplete rubella vaccination programs result in continued disease transmission as evidenced by recent large outbreaks in Japan and elsewhere. Herein, we provide current results regarding rubella control, elimination and eradication policies, and a brief review of new laboratory diagnostics. In addition, we provide novel information regarding rubella vaccine immunogenetics and review the emerging evidence of inter-individual variability in humoral and cell-mediated innate and adaptive immune responses to rubella vaccine and their association with HLA alleles, haplotypes, and single nucleotide polymorphisms across the human genome. Finally, we conclude with a call for further research in rubella vaccine immunogenetics and its ability to inform a vaccinomics-level approach to novel vaccine candidate development and the need for a next generation vaccine that is affordable, easy to administer, and does not require a cold chain for optimal immunogenicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Duvanel, C. B., Honegger, P., & Matthieu, J. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1173 · Cited by 25
RetractedTowards a knowledge-based Human Protein Atlas
Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E., Jonasson, K., Forsberg, M., Zwahlen, M., Kampf, C., Wester, K., Hober, S., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt1210-1248 · Cited by 2,440
Duration of Humoral Immunity to Common Viral and Vaccine Antigens
Amanna, I. J., Carlson, N. E., & Slifka, M. K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066092 · Cited by 1,286
Manual of Clinical Microbiology
(2011) · Wiley eBooks · doi:10.1128/9781555816728 · Cited by 1,003
The Xs and Y of immune responses to viral vaccines
Klein, S. L., Jedlicka, A., & Pekosz, A. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70049-9 · Cited by 815
CONSEQUENCES OF CONFIRMED MATERNAL RUBELLA AT SUCCESSIVE STAGES OF PREGNANCY
Miller, E., Cradock-Watson, J., & Pollock, T. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92677-0 · Cited by 631
(2013) · Vaccine · doi:10.1016/j.vaccine.2013.02.015 · Cited by 551
Davidkin, I., Jokinen, S., Broman, M., Leinikki, P., & Peltola, H. (2008) · The Journal of Infectious Diseases · doi:10.1086/528993 · Cited by 329
Banatvala, J., & Brown, D. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15897-2 · Cited by 289
Cited by
Zika virus — reigniting the TORCH
Coyne, C. B., & Lazear, H. M. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.125 · Cited by 355
Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes
Panchaud, A., Stojanov, M., Ammerdorffer, A., Vouga, M., & Baud, D. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00014-16 · Cited by 171
Metadata
- Authors
- Lambert, N., Strebel, P., Orenstein, W., Icenogle, J., & Poland, G. A.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 385
- Issue
- 9984
- Pages
- 2297-2307
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W4210365593
- Cited by
- 304
- References
- 56
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rubella. https://app.cochat.ai/papers/10.1016/s0140-6736(14)60539-0
- The paper
- Lambert, N., Strebel, P., Orenstein, W., Icenogle, J., & Poland, G. A. (2015). Rubella. The Lancet. https://doi.org/10.1016/s0140-6736(14)60539-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.